Tomy Digital Biology has been appointed as the Japanese distributor for the Modiro PTM analysis tool from German-based bioinformatics provider Protagen.
Modiro is already sold in in both Europe and the USA. Through this agreement with Tomy Digital Biology, Protagen will gain an established distributor for the commercialisation of its product in the Japanese market.
It is hoped that Tomy Digital Biology will reach research institutes such as the Riken-Brain Institute and the Osaka National Research Institute.
Dr Christoph Hüls, CEO of Protagen, said: ‘The signing of this commercialisation agreement demonstrates the continued advance of Protagen into the Asian market, which began with the research collaboration with Kangdi Antibody Biotech and Bejing Proteome Research Centre announced earlier this year.’